BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
7.81
-0.42 (-5.10%)
At close: Jun 5, 2026, 4:00 PM EDT
7.81
0.00 (0.00%)
After-hours: Jun 5, 2026, 4:01 PM EDT
BBOT Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $21 | Buy | Maintains | $21 | +168.89% | Jun 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $18 | Buy | Maintains | $18 | +130.47% | May 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $25 | Buy | Maintains | $25 | +220.10% | May 14, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $23 | Buy | Maintains | $23 | +194.49% | May 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $22 | Buy | Reiterates | $22 | +181.69% | May 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $23 | Buy | Maintains | $23 | +194.49% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $29 | Buy | Reiterates | $29 | +271.32% | May 1, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $41 | Buy | Reiterates | $41 | +424.97% | Mar 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.